PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWetherspoon (J.D) Regulatory News (JDW)

Share Price Information for Wetherspoon (J.D) (JDW)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 806.50
Bid: 804.50
Ask: 805.50
Change: 4.50 (0.56%)
Spread: 1.00 (0.124%)
Open: 798.00
High: 807.00
Low: 792.00
Prev. Close: 802.00
JDW Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

7 Nov 2022 14:24

RNS Number : 5704F
Wetherspoon (JD) PLC
07 November 2022
 

7 November 2022

J D WETHERSPOON PLC

Notification of transactions of directors, persons discharging managerial responsibility (PDMR) or connected persons

The Company was informed on 4 November 2022 that John Hutson, Chief Executive, acquired 5809 ordinary shares of the Company on the vest of an award under the Company's 2022 Deferred Bonus Scheme on 4 November at a price of 467.00 pence.

The Company was informed on 4 November 2022 that David Capstick, IT & Property Director, acquired 2940 ordinary shares of the Company on the vest of an award under the Company's 2022 Deferred Bonus Scheme on 4 November at a price of 467.00 pence.

The Company was informed on 4 November 2022 that Martin Geoghegan, Operations Director, acquired 2310 ordinary shares of the Company on the vest of an award under the Company's 2022 Deferred Bonus Scheme on 4 November at a price of 467.00 pence.

The Company was informed on 4 November 2022 that Benjamin Whitley, Finance Director, acquired 2275 ordinary shares of the Company on the vest of an award under the Company's 2022 Deferred Bonus Scheme on 4 November at a price of 467.00 pence.

The Company was informed on 4 November 2022 that James Ullman, Audit Director, acquired 1387 ordinary shares of the Company on the vest of an award under the Company's 2022 Deferred Bonus Scheme on 4 November at a price of 467.00 pence.

The Company was informed on 4 November 2022 that Nigel Connor, Company Secretary / Legal Director, acquired 1054 ordinary shares of the Company on the vest of an award under the Company's 2022 Deferred Bonus Scheme on 4 November at a price of 467.00 pence.

The Company was informed on 4 November 2022 that Michael Barron, Commercial Director, acquired 913 ordinary shares of the Company on the vest of an award under the Company's 2022 Deferred Bonus Scheme on 4 November at a price of 467.00 pence.

The Company was informed on 4 November 2022 that Paul Brimmer, Purchasing Director, acquired 905 ordinary shares of the Company on the vest of an award under the Company's 2022 Deferred Bonus Scheme on 4 November at a price of 467.00 pence.

The Company was informed on 4 November 2022 that Tom Ball, People Director, acquired 894 ordinary shares of the Company on the vest of an award under the Company's 2022 Deferred Bonus Scheme on 4 November at a price of 467.00 pence.

The Company was informed on 4 November 2022 that Hannah Young, Deputy Finance Director, acquired 313 ordinary shares of the Company on the vest of an award under the Company's 2022 Deferred Bonus Scheme on 4 November at a price of 467.00 pence.

Enquiries:

John Hutson Chief Executive Officer 07970 477377

Ben Whitley Finance Director 07970 477428

Eddie Gershon Company Spokesman 07956 392234

 

Please send any questions by email to investorqueries@jdwetherspoon.co.uk

 

Notes to editors

1. J D Wetherspoon owns and operates pubs throughout the UK. The company aims to provide customers with good-quality food and drink, served by well-trained and friendly staff, at reasonable prices. The pubs are individually designed, and the company aims to maintain them in excellent condition.

 

2. Visit our website: www.jdwetherspoon.com

 

3. This announcement has been prepared solely to provide additional information to the shareholders of J D Wetherspoon, to meet the requirements of the FCA's Disclosure and Transparency Rules. It should not be relied on by any other party, for any other purposes. Forward-looking statements have been made by the directors in good faith, using information available up until the date on which they approved this statement. Forward-looking statements should be regarded with caution, because of the inherent uncertainties in economic trends and business risks.

 

4. The current financial year comprises 52 trading weeks to 30 July 2023.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBSBDBDDGDGDR
Date   Source Headline
26th Jan 20215:40 pmRNSDirector/PDMR Shareholding
26th Jan 20212:31 pmRNSHolding(s) in Company
22nd Jan 20213:48 pmRNSDirector/PDMR Shareholding
22nd Jan 20213:32 pmRNSNews Release - Correction
22nd Jan 20212:52 pmRNSHolding(s) in Company
22nd Jan 20212:26 pmRNSHolding(s) in Company
21st Jan 202111:57 amRNSDirector/PDMR Shareholding
20th Jan 20217:00 amRNSResults of the Placing
19th Jan 20214:48 pmRNSProposed Placing of Ordinary Shares
19th Jan 20214:44 pmRNSFurther Covid-19 Update, Equity Placing
22nd Dec 202012:21 pmRNSDirector/PDMR Shareholding
17th Dec 20203:44 pmRNSResult of AGM
17th Dec 20207:00 amRNSAnnual General Meeting Announcement
11th Dec 202010:12 amRNSPress Release
8th Dec 20208:02 amRNSHolding(s) in Company
2nd Dec 20201:00 pmRNSDirector/PDMR Shareholding
27th Nov 20207:00 amRNSBusiness Update
24th Nov 20201:16 pmRNSDirector/PDMR Shareholding
18th Nov 20207:00 amRNSHolding(s) in Company
17th Nov 202010:33 amRNSNotice of AGM
11th Nov 20207:00 amRNSTrading Update
3rd Nov 202012:20 pmRNSAppointment of Non-Executive
2nd Nov 20202:48 pmRNSDirector/PDMR Shareholding
21st Oct 20204:31 pmRNSAnnual Financial Report
21st Oct 20203:18 pmRNSReplacement Preliminary Results
20th Oct 20204:38 pmRNSDirector/PDMR Shareholding
16th Oct 20207:00 amRNSPreliminary Results
30th Sep 20203:04 pmRNSRevised results date
16th Sep 202011:29 amRNSDirector/PDMR Shareholding
16th Sep 202011:29 amRNSDirector/PDMR Shareholding
16th Sep 202011:28 amRNSDirector/PDMR Shareholding
16th Sep 202011:28 amRNSDirector/PDMR Shareholding
16th Sep 202011:28 amRNSDirector/PDMR Shareholding
16th Sep 202011:17 amRNSDirector/PDMR Shareholding
14th Sep 20207:00 amRNSUpdate Announcement
24th Aug 20207:00 amRNSUpdate Announcement
14th Aug 20206:32 pmRNSHolding(s) in Company
12th Aug 20202:00 pmRNSWE NEED MORE TRANSPARENNCY ON COVID DATA
15th Jul 20203:49 pmRNSHolding(s) in Company
13th Jul 20203:47 pmRNSHolding(s) in Company
10th Jul 20206:00 pmRNSDirector/PDMR Shareholding
7th Jul 20207:00 amRNSCorrection - Daily Mail
24th Jun 20207:00 amRNSFurther update on COVID-19
7th May 20208:00 amRNSCorrection - Forbes
5th May 20201:33 pmRNSHolding(s) in Company
5th May 20201:20 pmRNSHolding(s) in Company
4th May 20203:22 pmRNSHolding(s) in Company
4th May 20201:00 pmRNSDirector/PDMR Shareholding
4th May 202010:30 amRNSHolding(s) in Company
30th Apr 20207:00 amRNSResults of the placing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.